Opportunity Information: Apply for PAR 15 334
Apply for PAR 15 334
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396 Cancer Biology Research.
- This funding opportunity was created on Aug 18, 2015 and posted on Aug 18, 2015.
- Applicants must submit their applications by Jun 14, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal governments (Federally recognized) Independent school districts Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) is a National Institutes of Health funding opportunity (NCI, under the Informatics Technology for Cancer Research or ITCR Initiative) that supports early stage, exploratory research aimed at creating new computational approaches for cancer. The focus is not on incremental software improvements, but on genuinely novel methods, algorithms, and analytical approaches in biomedical computing, informatics, and data science that could meaningfully improve how cancer related data and knowledge are collected, organized, analyzed, shared, and used across the cancer research and care landscape.
The FOA is designed to address priority needs across the entire cancer research continuum. That includes projects relevant to cancer biology, cancer diagnosis and treatment, cancer prevention, cancer control and epidemiology, and cancer health disparities. In practice, this means a proposal could target anything from new statistical or machine learning methods for analyzing high dimensional molecular data, to better algorithms for integrating clinical and research datasets, to innovative ways of representing, querying, and disseminating cancer knowledge so that it becomes more usable by researchers and, potentially, health systems. What ties all of these together is the expectation that the work is method driven and that it fills an informatics gap that is limiting progress in cancer research or management.
Because this is part of ITCR, there is a strong emphasis on research driven informatics technology across the development lifecycle, with this particular R21 mechanism aimed at exploratory and developmental concepts. Applications are expected to make a clear case for why the proposed method or algorithm is new, what problem it solves that existing approaches do not, and how the result would benefit the cancer research field. Reviewers would typically look for a persuasive rationale, evidence that the idea is feasible enough to test within an R21 scope, and a credible path showing how the resulting method could influence cancer research workflows or enable analyses that are not currently practical. The announcement also notes that investigators who want to do more downstream tool development work (for example, building full prototypes, hardening software, or adapting tools for broader deployment) should consider related companion FOAs intended for those later stage activities, rather than forcing a tool building agenda into this R21.
Administratively, this is a discretionary grant opportunity using the NIH R21 exploratory/developmental mechanism. The opportunity number is PAR-15-334, with a posted and creation date of August 18, 2015. The original and final closing date listed is June 14, 2018, and the archive date is July 15, 2018, meaning this particular announcement is no longer active, but it remains useful as a reference point for ITCR priorities and the kinds of projects NCI has sought to stimulate. The listed award ceiling is $200,000, and there is no cost sharing or matching requirement. The CFDA listing includes 93.396 (Cancer Biology Research), reflecting the cancer focused mission even though the technical scope is informatics and data science.
Eligibility is broad and includes many types of domestic U.S. organizations and government entities, as well as certain non-U.S. entities as specified. Eligible applicants include public and private institutions of higher education, nonprofits with and without 501(c)(3) status (with the stated exception categories), for profit organizations other than small businesses, and small businesses. Government applicants may include state, county, city or township governments, independent school districts, special district governments, public housing authorities/Indian housing authorities, and tribal governments or tribal organizations (including both federally recognized and other than federally recognized categories as listed). The FOA also explicitly references additional eligible groups such as historically Black colleges and universities, Hispanic serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and Asian American and Native American Pacific Islander serving institutions, as well as faith based or community based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. In other words, the program is structured to allow a wide range of institutions to compete, provided they can deliver a high quality, cancer relevant informatics innovation.
For applicants or readers looking for the full official text, the announcement points to the NIH grants guide page at http://grants.nih.gov/grants/guide/pa-files/PAR-15-334.html. For technical access issues, the contact listed is the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is this funding opportunity?
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) is a National Institutes of Health (NIH) funding opportunity led by the National Cancer Institute (NCI) under the Informatics Technology for Cancer Research (ITCR) Initiative. It supports early-stage, exploratory research proposing genuinely novel computational methods, algorithms, and analytical approaches that could improve how cancer-related data and knowledge are collected, organized, analyzed, shared, and used across cancer research and care.
What is the FOA number for this opportunity?
The FOA number is PAR-15-334.
Which NIH mechanism does this opportunity use?
This opportunity uses the NIH R21 exploratory/developmental research grant mechanism, which is intended for early-stage, exploratory and developmental concepts.
Who is sponsoring this opportunity?
The sponsoring NIH component is the National Cancer Institute (NCI), and the program sits within NCI's Informatics Technology for Cancer Research (ITCR) Initiative.
What kinds of projects does this FOA aim to fund?
The FOA aims to fund method-driven informatics innovation for cancer, including new computational approaches in biomedical computing, informatics, and data science. The expectation is that the work fills an informatics gap that is limiting progress in cancer research or management.
What is the main emphasis of the research proposed under this FOA?
The emphasis is on creating genuinely novel methods, algorithms, and analytical approaches rather than incremental improvements to existing software. Applications are expected to clearly explain what is new, what problem the innovation solves that existing approaches do not, and how it would benefit the cancer research field.
Are incremental software improvements responsive to this FOA?
No. The FOA specifically notes that the focus is not on incremental software improvements. It prioritizes new methods and algorithms that represent meaningful innovation.
What parts of the cancer research continuum can be addressed?
The FOA is designed to address priority needs across the entire cancer research continuum. This includes cancer biology, cancer diagnosis and treatment, cancer prevention, cancer control and epidemiology, and cancer health disparities.
Can proposals focus on statistical or machine learning methods?
Yes. Examples described include new statistical or machine learning methods for analyzing high-dimensional molecular data.
Can proposals focus on integrating clinical and research datasets?
Yes. The FOA includes examples such as better algorithms for integrating clinical and research datasets.
Can proposals focus on knowledge representation and querying?
Yes. The FOA mentions innovative ways of representing, querying, and disseminating cancer knowledge to make it more usable by researchers and potentially health systems.
What do reviewers typically look for in applications?
Based on the FOA description, reviewers would typically look for a persuasive rationale for why the proposed method or algorithm is new, evidence that the idea is feasible enough to test within an R21 scope, and a credible path showing how the resulting method could influence cancer research workflows or enable analyses that are not currently practical.
Is this FOA intended for full tool development and broader deployment work?
This R21 is aimed at exploratory and developmental concepts. The announcement notes that investigators who want to pursue more downstream tool development (such as building full prototypes, hardening software, or adapting tools for broader deployment) should consider related companion FOAs intended for later-stage activities, rather than pushing a tool-building agenda into this R21.
Is this funding opportunity still active?
No. The original and final closing date listed is June 14, 2018, and the archive date is July 15, 2018. That means this particular announcement is no longer active, though it may still be useful as a reference for ITCR priorities and the kinds of projects NCI has sought to stimulate.
When was the opportunity posted?
The posted and creation date listed is August 18, 2015.
What is the award ceiling listed for this opportunity?
The listed award ceiling is $200,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
What CFDA number is associated with this opportunity?
The CFDA listing includes 93.396 (Cancer Biology Research).
Who is eligible to apply?
Eligibility is broad. Eligible applicants include many types of domestic U.S. organizations and government entities, as well as certain non-U.S. entities as specified in the FOA. The eligible categories described include public and private institutions of higher education; nonprofits with and without 501(c)(3) status (with stated exception categories); for-profit organizations other than small businesses; and small businesses.
Are government entities eligible to apply?
Yes. Government applicants may include state governments; county governments; city or township governments; independent school districts; special district governments; public housing authorities/Indian housing authorities; and tribal governments or tribal organizations (including both federally recognized and other than federally recognized categories, as listed).
Are minority-serving institutions explicitly included in the eligible applicants list?
Yes. The FOA explicitly references eligible groups such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations among eligible applicants.
Are U.S. territories or possessions included in the eligibility language?
Yes. The FOA explicitly references U.S. territories or possessions as eligible.
Are federal agencies eligible to apply?
Yes. The eligibility list includes eligible federal agencies.
Where can I find the official FOA text?
The announcement points to the NIH Grants Guide page at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-334.html.
Who is the contact for technical access issues with the FOA page?
The listed contact for technical access issues is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: PPHF 2015 Immunization Utilization of Immunization Information Systems (IIS) for Assessment, Feedback,
Previous opportunity: Media Outreach Channel Islands, CA
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 334
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 334) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploratory Multi site Palliative Care Research in Diverse Populations Utilizing the Palliative Care Research Cooperative (PCRC) Group (R21) Apply for PAR 15 337 Funding Number: PAR 15 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NIDA Translational Avant Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) Apply for RFA DA 16 008 Funding Number: RFA DA 16 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 15 340 Funding Number: PAR 15 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Centers for Cancer Systems Biology Consortium(U54) Apply for RFA CA 15 014 Funding Number: RFA CA 15 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,500,000 |
| Coordinating Center for Cancer Systems Biology Consortium (U24) Apply for RFA CA 15 015 Funding Number: RFA CA 15 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Behavioral Pharmacology and Genetics Translating and Targeting Individual Differences (R03) Apply for RFA DA 09 016 Funding Number: RFA DA 09 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biosignatures of Chronic Drug Exposure (R21) Apply for RFA DA 09 022 Funding Number: RFA DA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01) Apply for PAS 09 001 Funding Number: PAS 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants Program for Cancer Epidemiology (R03) Apply for PAR 08 237 Funding Number: PAR 08 237 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Unique Interactions Between Tobacco Use and HIV/AIDS (R01) Apply for PA 08 253 Funding Number: PA 08 253 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Unique Interactions Between Tobacco Use and HIV/AIDS (R03) Apply for PA 08 254 Funding Number: PA 08 254 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R01) Apply for PA 08 263 Funding Number: PA 08 263 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants for Behavioral Research in Cancer Control (R03) Apply for PAR 09 003 Funding Number: PAR 09 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery(R01) Apply for PA 09 004 Funding Number: PA 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery (R21) Apply for PA 09 005 Funding Number: PA 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R21) Apply for PA 08 264 Funding Number: PA 08 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R03) Apply for PA 08 265 Funding Number: PA 08 265 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) Apply for PA 08 267 Funding Number: PA 08 267 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Interactions between Physical Activity and Drug Abuse (R01) Apply for RFA DA 09 013 Funding Number: RFA DA 09 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Interactions between Physical Activity and Drug Abuse (R03) Apply for RFA DA 09 014 Funding Number: RFA DA 09 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 334", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.